- Q2 sales EUR 43m, -7% y-o-y, order intake EUR 40m, +11% y-o-y - Minor adjustments to '24-'26 estim...
- 3% organic sales growth y-o-y - Lower profitability than we expected - Adj.
Vaisala’s delivered very strong figures for Q2/24 as our estimates were topped on both net sales and...
- Orders -6% vs ABGSCe, sales in line, EBIT 31% above - Adj.
- EBIT SEK 30m vs. ABGSCe SEK 63m; Q3e likely better - Pulp prices at ATHs, but may have peaked shor...
Redeye briefly comments on Mendus announcing a collaboration with Institut Bergonié that involves tr...
- EBIT SEK 30m vs. ABG SEK 63m - Q3 likely stronger — Rottneros Mill maintenance moved to Q4 - Confe...
- Organic growth of 9% vs. cons. 9.5% - Adj. EBITA SEK 141m, 3% below consensus - Gross margin gains...
A tender offer was made for Innofactor’s shares, with the offer price set at EUR 1.
- 6% organic growth despite headwinds in major markets - Strong margins highlight low guidance into ...
- Minor positive estimate revisions - Expect primarily volume-driven growth - FVR of SEK 20-35 reite...
- Q2 was likely the trough - Small estimate revisions, good prospects for a better H2 - Poised for i...
Redeye remains confident on the case, despite the unexpected news of CEO Axel Berntsson leaving the ...
Redeye is surprised to hear that CEO Axel Berntsson is leaving the company to take on the role as CE...
Vaisala reports its Q2/24 results on Thursday 25th of July.
